Xiangbin prescription for the recovery of gastrointestinal function after abdominal surgery (the XBPRS trial): study protocol for a randomized controlled trial.

ABSTRACT:

Background

Most patients who undergo abdominal surgery recover bowel movements within a week; however, some suffer prolonged intestinal paralysis or postoperative ileus (POI) leading to complications, such as infection and intestinal adhesions, which can extend hospitalization and increase readmission rates, and consequently increasing healthcare costs. Chinese medicine is effective for accelerating the recovery of gastrointestinal function after abdominal surgery. Xiangbin prescription (XBP) is the standard prescription for this purpose in our hospital; however, randomized controlled trials of it have not yet been conducted.

Methods/design

This double-blind, randomized controlled clinical trial aims to recruit patients who have undergone abdominal surgery and experienced po

SUBMITTER: Gan H 

PROVIDER: S-EPMC5830341 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature